{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:02:52Z","timestamp":1772852572815,"version":"3.50.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"DOI":"10.1086\/524041","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T04:47:56Z","timestamp":1200372476000},"page":"1-13","source":"Crossref","is-referenced-by-count":55,"title":["Economics of an Adolescent Meningococcal Conjugate Vaccination Catch-up Campaign in the United States"],"prefix":"10.1093","volume":"46","author":[{"given":"Ismael R.","family":"Ortega Sanchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin I.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Shepard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Zell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Messonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Bilukha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Messonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,1,1]]},"reference":[{"key":"key\n\t\t\t\t20170522091537_ref1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jama.286.6.694","article-title":"Invasive meningococcal disease in adolescents and young adults","volume":"286","author":"Harrison","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522091537_ref2","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522091537_ref3","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522091537_ref4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.med.55.091902.103612","article-title":"Opportunities for control of meningococcal disease in the United States","volume":"55","author":"Raghunathan","year":"2004","journal-title":"Annu Rev Med"},{"key":"key\n\t\t\t\t20170522091537_ref5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.38725.728472.BE","article-title":"Risk and protective factors for meningococcal disease in adolescents: matched cohort study","volume":"332","author":"Tully","year":"2006","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170522091537_ref6","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1086\/345763","article-title":"Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diptheria toxoid conjugate vaccine given to healthy adults","volume":"186","author":"Campbell","year":"2002","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522091537_ref7","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1542\/peds.2004-2514","article-title":"Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States","volume":"115","author":"Shepard","year":"2005","journal-title":"Pediatrics"},{"issue":"RR07","key":"key\n\t\t\t\t20170522091537_ref8","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Center for Disease Control Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170522091537_ref9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C vaccination in toddlers and teenagers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522091537_ref10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","article-title":"Impact of meningococcal C conjugate vaccine in the UK","volume":"51","author":"Balmer","year":"2002","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20170522091537_ref11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170522091537_ref12","volume-title":"Annual estimates of the population for the United States, regions, and states, and for Puerto Rico: April 1, 2000 to July 1, 2005 (NST-EST2004-01)","author":"US Census"},{"key":"key\n\t\t\t\t20170522091537_ref13","first-page":"245","article-title":"Appendix I: productivity loss tables","volume-title":"Prevention effectiveness: a guide to decision analysis and economic evaluation","author":"Gross","year":"2003"},{"key":"key\n\t\t\t\t20170522091537_ref14","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"A practical guide to cost-effectiveness in health and medicine","author":"Gold","year":"1996"},{"key":"key\n\t\t\t\t20170522091537_ref15","volume-title":"National Notifiable Disease Surveillance System","author":"Centers for Disease Control and Prevention"},{"key":"key\n\t\t\t\t20170522091537_ref16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/322587","article-title":"Complications of meningococcal disease in college students","volume":"33","author":"Erickson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522091537_ref17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00006454-199611000-00009","article-title":"Pathophysiology, treatment, and outcome of meningococcemia: a review and recent experience","volume":"15","author":"Kirsch","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170522091537_ref18","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/archinte.159.19.2329","article-title":"Meningococcal disease in a large urban population (Barcelona 1987\u20131992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group","volume":"159","author":"Barquet","year":"1999","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170522091537_ref19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0163-4453(83)90443-7","article-title":"Sequelae from bacterial meningitis and their relation to the clinical condition during acute illness, based on 667 questionnaire returns: part II of a three part series","volume":"7","author":"Bohr","year":"1983","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170522091537_ref20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00006454-199305000-00008","article-title":"Outcome of bacterial meningitis: a meta-analysis","volume":"12","author":"Baraff","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170522091537_ref21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00005373-199804000-00011","article-title":"Long-term psychosocial adaptation of children who survive burns involving 80% or greater total body surface area","volume":"44","author":"Blakeney","year":"1998","journal-title":"J Trauma"},{"key":"key\n\t\t\t\t20170522091537_ref22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.283.1.69","article-title":"Long-term outcome of children surviving massive burns","volume":"283","author":"Sheridan","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522091537_ref23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8727(00)00133-1","article-title":"Health-related quality of life in patients with diabetes mellitus and foot ulcers","volume":"14","author":"Tennvall","year":"2000","journal-title":"J Diabetes Complications"},{"key":"key\n\t\t\t\t20170522091537_ref24","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1017\/S0266462300102132","article-title":"The effect of cochlear implant use in postlingually deaf adults","volume":"16","author":"Krabbe","year":"2000","journal-title":"Int J Technol Assess Health Care"},{"key":"key\n\t\t\t\t20170522091537_ref25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jama.284.7.850","article-title":"Cost-utility analysis of the cochlear implant in children","volume":"284","author":"Cheng","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522091537_ref26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/0272989X0002000405","article-title":"A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease","volume":"20","author":"Neumann","year":"2000","journal-title":"Med Decis Making"},{"key":"key\n\t\t\t\t20170522091537_ref27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(03)12563-9","article-title":"Efficacy of meningococcal C conjugate vaccine in teenagers in England","volume":"361","author":"Bose","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522091537_ref28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522091537_ref29","first-page":"660","article-title":"Effectiveness of a middle school vaccination law\u2014California, 1999\u20132001","volume":"50","author":"Centers for Disease Control Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170522091537_ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.324.7341.809","article-title":"Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales","volume":"324","author":"Trotter","year":"2002","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170522091537_ref31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0749-3797(02)00462-2","article-title":"Vaccinating first-year college students living in dormitories for meningococcal disease","volume":"23","author":"Scott","year":"2002","journal-title":"Am J Prev Med"},{"key":"key\n\t\t\t\t20170522091537_ref32","first-page":"87","article-title":"Utilization of and expenditures for medicaid institutional and home and community based services","volume-title":"Residential services for persons with developmental disabilities: status and trends through 2002","author":"Lakin","year":"2003"},{"key":"key\n\t\t\t\t20170522091537_ref33","volume-title":"Active Bacterial Core Surveillance (ABC)","author":"Centers for Disease Control and Prevention"},{"key":"key\n\t\t\t\t20170522091537_ref34","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"UK Meningococcal Carriage Group. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522091537_ref35","volume-title":"Gross Domestic Product deflator"},{"key":"key\n\t\t\t\t20170522091537_ref36","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.283.11.1460","article-title":"Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children","volume":"283","author":"Lieu","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522091537_ref37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1542\/peds.113.2.283","article-title":"Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine","volume":"113","author":"Prosser","year":"2004","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170522091537_ref38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00003086-199404000-00024","article-title":"Long-term comparison of major limb salvage using the Iliazarov method versus amputation","volume":"301","author":"Williams","year":"1994","journal-title":"Clin Orthop Relat Res"},{"key":"key\n\t\t\t\t20170522091537_ref39","first-page":"57","article-title":"Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment\u2014United States, 2003","volume":"53","author":"Centers for Disease Control Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20170522091537_ref40","article-title":"Total expenditures for students with disabilities, 1999\u20132000: spending variation by disability. SEEP Report # 5","volume-title":"American Institutes for Research. June","author":"Chambers","year":"2003"},{"key":"key\n\t\t\t\t20170522091537_ref41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archpedi.154.8.797","article-title":"Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997","volume":"154","author":"Ekwueme","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key\n\t\t\t\t20170522091537_ref42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1086\/378987","article-title":"An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States","volume":"189","author":"Zhou","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522091537_ref43","first-page":"107","article-title":"Economic analyses of vaccines and vaccination programs","volume-title":"New generation vaccines","author":"Schwartz","year":"2004","edition":"3rd ed."},{"key":"key\n\t\t\t\t20170522091537_ref44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1517\/14656566.5.4.855","article-title":"Meningococcal conjugate vaccines","volume":"5","author":"Zimmer","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t20170522091537_ref45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.inf.0000160918.72953.51","article-title":"Pertussis immunization of adolescents in the United States: an economic evaluation","volume":"24","author":"Caro","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170522091537_ref46","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid1011.040222","article-title":"Evaluating human papillomavirus vaccination programs","volume":"10","author":"Taira","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170522091537_ref47","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1001\/jama.1992.03480130153046","article-title":"Mass voluntary immunization campaigns for meningococcal disease in Canada: media hysteria","volume":"267","author":"Hume","year":"1992","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522091537_ref48","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1016\/S0264-410X(01)00209-2","article-title":"Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States","volume":"19","author":"Lingappa","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522091537_ref49","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1001\/jama.283.21.2842","article-title":"New opportunities for prevention of meningococcal disease","volume":"283","author":"Perkins","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522091537_ref50","volume-title":"ACIP VFC vaccine resolutions","author":"Centers for Disease Control and Prevention"},{"key":"key\n\t\t\t\t20170522091537_ref51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/aje\/kwi160","article-title":"Dynamic models on meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination","volume":"162","author":"Trotter","year":"2005","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170522091537_ref52","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.vaccine.2003.09.022","article-title":"Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease","volume":"22","author":"De Wals","year":"2004","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522091537_ref53","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3201\/eid0812.040421","article-title":"Mass vaccination following community outbreak of meningococcal disease","volume":"8","author":"Krause","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170522091537_ref54","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1017\/S0266462300103162","article-title":"The societal costs of severe to profound hearing loss in the United States","volume":"16","author":"Mohr","year":"2000","journal-title":"Int J Technol Assess Health Care"},{"key":"key\n\t\t\t\t20170522091537_ref55","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0140-6736(95)90272-4","article-title":"After the honeymoon in measles control","volume":"345","author":"McLean","year":"1995","journal-title":"Lancet"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/46\/1\/1\/17349384\/46-1-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T07:42:00Z","timestamp":1708501320000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/524041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,1]]},"published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1086\/524041","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}